FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080971266> ?p ?o ?g. }

• W2080971266 endingPage "572" @default.
• W2080971266 startingPage "565" @default.
• W2080971266 abstract "(131)I-meta-iodobenzylguanidine ((131)I-MIBG) has been in therapeutic use since 1980s. Newer treatment modalities are emerging for neuroendocrine tumours (NETs) and chromaffin cell tumours (CCTs), but many of these do not yet have adequate long-term follow-up to determine their longer term efficacy and sequelae.Fifty-eight patients with metastatic NETs and CCTs who had received (131)I-MIBG therapy between 2000 and 2011 were analysed. Survival and any long-term haematological or renal sequelae were investigated.In the NET group, the overall median survival and median survival following the diagnosis of metastatic disease was 124 months. The median survival following the commencement of (131)I-MIBG was 66 months. For the CCT group, median survival had not been reached. The 5-year survival from diagnosis and following the diagnosis of metastatic disease was 67% and 67.5% for NETs and CCTs, respectively. The 5-year survival following the commencement of (131)I-MIBG therapy was 68%. Thirty-two patients had long-term haematological sequelae: 5 of these 32 patients developed haematological malignancies. Two patients developed a mild deterioration in renal function.Long follow up of (131)I-MIBG therapy reveals a noteable rate of bone marrow toxicities and malignancy and long term review of all patients receiving radionuclide therapies is recommended." @default.
• W2080971266 created "2016-06-24" @default.
• W2080971266 creator A5005612990 @default.
• W2080971266 creator A5007146189 @default.
• W2080971266 creator A5030879870 @default.
• W2080971266 creator A5046852415 @default.
• W2080971266 creator A5047568561 @default.
• W2080971266 creator A5057494293 @default.
• W2080971266 creator A5067447666 @default.
• W2080971266 creator A5068609012 @default.
• W2080971266 creator A5090508248 @default.
• W2080971266 date "2013-07-16" @default.
• W2080971266 modified "2023-10-18" @default.
• W2080971266 title "Sequelae and survivorship in patients treated with 131I-MIBG therapy" @default.
• W2080971266 cites W1668008365 @default.
• W2080971266 cites W1966893598 @default.
• W2080971266 cites W1968058785 @default.
• W2080971266 cites W1968626722 @default.
• W2080971266 cites W1979996066 @default.
• W2080971266 cites W1987373615 @default.
• W2080971266 cites W2014505054 @default.
• W2080971266 cites W2024061959 @default.
• W2080971266 cites W2031301095 @default.
• W2080971266 cites W2031576722 @default.
• W2080971266 cites W2033786785 @default.
• W2080971266 cites W2037479586 @default.
• W2080971266 cites W2042546294 @default.
• W2080971266 cites W2042767677 @default.
• W2080971266 cites W2047480171 @default.
• W2080971266 cites W2055454912 @default.
• W2080971266 cites W2060218822 @default.
• W2080971266 cites W2072150736 @default.
• W2080971266 cites W2081457024 @default.
• W2080971266 cites W2088392073 @default.
• W2080971266 cites W2092047830 @default.
• W2080971266 cites W2095058352 @default.
• W2080971266 cites W2098468148 @default.
• W2080971266 cites W2108613323 @default.
• W2080971266 cites W2115686439 @default.
• W2080971266 cites W2125025937 @default.
• W2080971266 cites W2134451629 @default.
• W2080971266 cites W2137142564 @default.
• W2080971266 cites W2137385634 @default.
• W2080971266 cites W2143973920 @default.
• W2080971266 cites W2146329736 @default.
• W2080971266 cites W2146946075 @default.
• W2080971266 cites W2148394335 @default.
• W2080971266 cites W2149214723 @default.
• W2080971266 cites W2158474413 @default.
• W2080971266 cites W2159009361 @default.
• W2080971266 cites W2160112776 @default.
• W2080971266 cites W2160463900 @default.
• W2080971266 cites W2167466716 @default.
• W2080971266 cites W2322936173 @default.
• W2080971266 cites W4240001798 @default.
• W2080971266 doi "https://doi.org/10.1038/bjc.2013.365" @default.
• W2080971266 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3738119" @default.
• W2080971266 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23860527" @default.
• W2080971266 hasPublicationYear "2013" @default.
• W2080971266 type Work @default.
• W2080971266 sameAs 2080971266 @default.
• W2080971266 citedByCount "33" @default.
• W2080971266 countsByYear W20809712662013 @default.
• W2080971266 countsByYear W20809712662014 @default.
• W2080971266 countsByYear W20809712662016 @default.
• W2080971266 countsByYear W20809712662017 @default.
• W2080971266 countsByYear W20809712662018 @default.
• W2080971266 countsByYear W20809712662019 @default.
• W2080971266 countsByYear W20809712662020 @default.
• W2080971266 countsByYear W20809712662021 @default.
• W2080971266 countsByYear W20809712662022 @default.
• W2080971266 countsByYear W20809712662023 @default.
• W2080971266 crossrefType "journal-article" @default.
• W2080971266 hasAuthorship W2080971266A5005612990 @default.
• W2080971266 hasAuthorship W2080971266A5007146189 @default.
• W2080971266 hasAuthorship W2080971266A5030879870 @default.
• W2080971266 hasAuthorship W2080971266A5046852415 @default.
• W2080971266 hasAuthorship W2080971266A5047568561 @default.
• W2080971266 hasAuthorship W2080971266A5057494293 @default.
• W2080971266 hasAuthorship W2080971266A5067447666 @default.
• W2080971266 hasAuthorship W2080971266A5068609012 @default.
• W2080971266 hasAuthorship W2080971266A5090508248 @default.
• W2080971266 hasBestOaLocation W20809712661 @default.
• W2080971266 hasConcept C126322002 @default.
• W2080971266 hasConcept C141071460 @default.
• W2080971266 hasConcept C143998085 @default.
• W2080971266 hasConcept C2776283816 @default.
• W2080971266 hasConcept C2779134260 @default.
• W2080971266 hasConcept C2779399171 @default.
• W2080971266 hasConcept C2993559085 @default.
• W2080971266 hasConcept C509974204 @default.
• W2080971266 hasConcept C71924100 @default.
• W2080971266 hasConceptScore W2080971266C126322002 @default.
• W2080971266 hasConceptScore W2080971266C141071460 @default.
• W2080971266 hasConceptScore W2080971266C143998085 @default.
• W2080971266 hasConceptScore W2080971266C2776283816 @default.
• W2080971266 hasConceptScore W2080971266C2779134260 @default.
• W2080971266 hasConceptScore W2080971266C2779399171 @default.

• next